Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 34 studies | 32% ± 10% | |
memory B cell | 19 studies | 34% ± 8% | |
naive B cell | 19 studies | 36% ± 8% | |
endothelial cell | 15 studies | 26% ± 9% | |
dendritic cell | 10 studies | 32% ± 11% | |
endothelial cell of vascular tree | 9 studies | 22% ± 4% | |
capillary endothelial cell | 8 studies | 21% ± 6% | |
conventional dendritic cell | 6 studies | 25% ± 7% | |
plasma cell | 6 studies | 25% ± 8% | |
immature B cell | 5 studies | 33% ± 8% | |
macrophage | 4 studies | 21% ± 5% | |
monocyte | 4 studies | 23% ± 4% | |
fibroblast | 4 studies | 27% ± 7% | |
myeloid cell | 4 studies | 24% ± 6% | |
non-classical monocyte | 4 studies | 22% ± 5% | |
basal cell | 4 studies | 21% ± 7% | |
germinal center B cell | 3 studies | 52% ± 14% |
Insufficient scRNA-seq data for expression of CD40 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1335.08 | 89 / 89 | 96% | 58.30 | 869 / 901 |
thymus | 100% | 1912.81 | 652 / 653 | 97% | 70.57 | 584 / 605 |
lung | 100% | 3003.03 | 578 / 578 | 93% | 47.31 | 1079 / 1155 |
pancreas | 100% | 1014.73 | 328 / 328 | 93% | 40.39 | 166 / 178 |
ovary | 100% | 2124.26 | 180 / 180 | 87% | 25.06 | 374 / 430 |
breast | 100% | 1848.88 | 459 / 459 | 85% | 19.79 | 947 / 1118 |
uterus | 100% | 1833.15 | 170 / 170 | 83% | 38.71 | 382 / 459 |
bladder | 100% | 1770.67 | 21 / 21 | 80% | 35.41 | 404 / 504 |
prostate | 100% | 2129.56 | 245 / 245 | 76% | 15.51 | 381 / 502 |
adrenal gland | 98% | 657.43 | 253 / 258 | 78% | 23.33 | 179 / 230 |
stomach | 99% | 1056.80 | 357 / 359 | 76% | 21.83 | 218 / 286 |
liver | 98% | 671.41 | 221 / 226 | 74% | 21.73 | 302 / 406 |
skin | 100% | 1071.82 | 1803 / 1809 | 71% | 24.42 | 337 / 472 |
intestine | 99% | 1229.04 | 959 / 966 | 68% | 18.01 | 356 / 527 |
esophagus | 100% | 1209.82 | 1444 / 1445 | 66% | 16.54 | 121 / 183 |
brain | 69% | 342.08 | 1836 / 2642 | 37% | 6.33 | 261 / 705 |
adipose | 100% | 2090.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 259.46 | 29 / 29 |
spleen | 100% | 3053.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 59.61 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.38 | 1 / 1 |
blood vessel | 100% | 1537.61 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 855.24 | 850 / 861 | 0% | 0 | 0 / 0 |
muscle | 87% | 447.17 | 700 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 75% | 3358.57 | 695 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 34% | 6.99 | 27 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0002768 | Biological process | immune response-regulating cell surface receptor signaling pathway |
GO_0023035 | Biological process | CD40 signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_1901652 | Biological process | response to peptide |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0042832 | Biological process | defense response to protozoan |
GO_0051607 | Biological process | defense response to virus |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0034341 | Biological process | response to type II interferon |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0030168 | Biological process | platelet activation |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0033590 | Biological process | response to cobalamin |
GO_0048304 | Biological process | positive regulation of isotype switching to IgG isotypes |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0042113 | Biological process | B cell activation |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0090037 | Biological process | positive regulation of protein kinase C signaling |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0036018 | Biological process | cellular response to erythropoietin |
GO_0042100 | Biological process | B cell proliferation |
GO_0019724 | Biological process | B cell mediated immunity |
GO_2000353 | Biological process | positive regulation of endothelial cell apoptotic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0035631 | Cellular component | CD40 receptor complex |
GO_0043025 | Cellular component | neuronal cell body |
GO_0009986 | Cellular component | cell surface |
GO_0043196 | Cellular component | varicosity |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0019899 | Molecular function | enzyme binding |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0003823 | Molecular function | antigen binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CD40 |
Protein name | CD40 ligand protein Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (CD40L receptor) Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40) CD40 antigen (TNF receptor superfamily member 5), isoform CRA_c (CD40 molecule) CD40 protein CD40 molecule CD40 molecule TNF receptor superfamily member 5 isoform 3 |
Synonyms | ligand hCG_40016 TNFRSF5 |
Description | FUNCTION: Receptor for TNFSF5/CD40LG . Transduces TRAF6- and MAP3K8-mediated signals that activate ERK in macrophages and B cells, leading to induction of immunoglobulin secretion (By similarity). . |
Accessions | Q6P2H9 ENST00000695671.1 ENST00000489304.6 ENST00000620709.4 A0A8Q3SI60 ENST00000466205.5 P25942 ENST00000372276.7 [P25942-2] A0A8Q3WKP3 A0A087X1D0 H0YE23 Q16063 A0A0S2Z349 ENST00000372285.8 [P25942-1] A0A8Q3WKP7 ENST00000477696.6 A0A0S2Z3C7 |